Villemure JG - Search Results

1

High dose tamoxifen in the treatment of recurrent high grade glioma: a report of clinical stabilization and tumour regression.

Baltuch G, Shenouda G, Langleben A, Villemure JG. Baltuch G, et al. Among authors: villemure jg. Can J Neurol Sci. 1993 May;20(2):168-70. doi: 10.1017/s0317167100047788. Can J Neurol Sci. 1993. PMID: 8334583

2

Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.

Baltuch GH, Couldwell WT, Villemure JG, Yong VW. Baltuch GH, et al. Among authors: villemure jg. Neurosurgery. 1993 Sep;33(3):495-501; discussion 501. doi: 10.1227/00006123-199309000-00021. Neurosurgery. 1993. PMID: 8413883

3

Protein kinase C and growth regulation of malignant gliomas.

Baltuch GH, Dooley NP, Villemure JG, Yong VW. Baltuch GH, et al. Among authors: villemure jg. Can J Neurol Sci. 1995 Nov;22(4):264-71. doi: 10.1017/s0317167100039457. Can J Neurol Sci. 1995. PMID: 8599768 Review.

4

Radiosurgery and accelerated radiotherapy for patients with glioblastoma.

Shenouda G, Souhami L, Podgorsak EB, Bahary JP, Villemure JG, Caron JL, Mohr G. Shenouda G, et al. Among authors: villemure jg. Can J Neurol Sci. 1997 May;24(2):110-5. doi: 10.1017/s0317167100021429. Can J Neurol Sci. 1997. PMID: 9164686 Clinical Trial.

5

Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.

Preul MC, Caramanos Z, Villemure JG, Shenouda G, LeBlanc R, Langleben A, Arnold DL. Preul MC, et al. Among authors: villemure jg. Neurosurgery. 2000 Feb;46(2):306-18. doi: 10.1097/00006123-200002000-00009. Neurosurgery. 2000. PMID: 10690719

6

Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.

Sankar T, Caramanos Z, Assina R, Villemure JG, Leblanc R, Langleben A, Arnold DL, Preul MC. Sankar T, et al. Among authors: villemure jg. J Neurooncol. 2008 Oct;90(1):63-76. doi: 10.1007/s11060-008-9632-3. Epub 2008 Jul 4. J Neurooncol. 2008. PMID: 18600428 Clinical Trial.

7

Protein kinase C isoform alpha overexpression in C6 glioma cells and its role in cell proliferation.

Baltuch GH, Dooley NP, Rostworowski KM, Villemure JG, Yong VW. Baltuch GH, et al. Among authors: villemure jg. J Neurooncol. 1995;24(3):241-50. doi: 10.1007/BF01052840. J Neurooncol. 1995. PMID: 7595754

8

T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism.

Baltuch GH, Villemure JG, McCrea E, Antel JP. Baltuch GH, et al. Among authors: villemure jg. Neurosurgery. 1994 Sep;35(3):450-6; discussion 456. doi: 10.1227/00006123-199409000-00013. Neurosurgery. 1994. PMID: 7800136

9

Apoptosis is induced in glioma cells by antisense oligonucleotides to protein kinase C alpha and is enhanced by cycloheximide.

Dooley NP, Baltuch GH, Groome N, Villemure JG, Yong VW. Dooley NP, et al. Among authors: villemure jg. Neuroreport. 1998 Jun 1;9(8):1727-33. doi: 10.1097/00001756-199806010-00011. Neuroreport. 1998. PMID: 9665591

10

Mechanisms of glioma invasion: role of matrix-metalloproteinases.

Uhm JH, Dooley NP, Villemure JG, Yong VW. Uhm JH, et al. Among authors: villemure jg. Can J Neurol Sci. 1997 Feb;24(1):3-15. doi: 10.1017/s0317167100021028. Can J Neurol Sci. 1997. PMID: 9043741 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters